Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomic-Based Decision Support to Predict Adherence to Medications.

Clinical pharmacology and therapeutics - 1 Aug 2020

Christian Carlton, Borden Brittany A, Danahey Keith, Yeo Kiang-Teck J, van Wijk Xander M R, Ratain Mark J, O'Donnell Peter H

Abstract excerpt

Poor adherence is associated with worse disease outcomes. Pharmacogenomics provides a possible intervention to address adherence. We hypothesized that pharmacogenomic-informed care could increase adherence. Patients in a prospective case-control study underwent preemptive pharmacogenomic genotyping with results available for provider use at the point of care; controls (not genotyped) were treated by the same...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Clinical Decision-Making

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Decision Support Techniques

Share to Medication Adherence

Share to Pharmacogenetics

Share to Pharmacogenomic Variants

Share to Precision Medicine

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 32236960
DOI: 10.1002/cpt.1838
PMCID: PMC7363565

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomic-Based Decision Support to Predict Adherence to Medications.PMID 32236960Read ↗

Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems.Semantic proximity Read ↗

Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping.Semantic proximity Read ↗

Improving Therapeutic Odyssey: Preemptive Pharmacogenomics Utility in Patient Care.Semantic proximity Read ↗

Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.Semantic proximity Read ↗

CLINICAL IMPLEMENTATION OF PREEMPTIVE PHARMACOGENOMICS TESTING FOR PERSONALIZED MEDICINE AT AN ACADEMIC MEDICAL CENTERSemantic proximity Read ↗

Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.Semantic proximity Read ↗

Real-world Clinical Effectiveness, Regulatory Transparency and Payer Coverage: Three Ingredients for Translating Pharmacogenomics into Clinical PracticeSemantic proximity Read ↗

Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.Semantic proximity Read ↗

A Framework to Quantify Disparities in Pharmacogenomic Treatment Concordance and Drug Response OutcomesSemantic proximity Read ↗

A Framework to Quantify Disparities in Pharmacogenomic Treatment Concordance and Drug Response Outcomes.Semantic proximity Read ↗

Genotype-predicted drug response phenotypes and their co-occurrence with dispensed medicines among 738,531 participants in the UK Our Future Health studySemantic proximity Read ↗

Disease-drug database for pharmacogenomic-based prescribing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.